Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.

Resmed has acquired VirtuOx, a Coral Springs, Fla.-based IDTF, to address a bottleneck in sleep apnea testing that is creating "one of the biggest barriers" to CPAP therapy, says Resmed Chief ...

The deal is set to enhance Resmed's ability to collaborate with healthcare providers to improve the diagnostic process.